Ixor

**Ixor** is an oral, multi-ingredient dietary supplement marketed by Moma Pharma. The historical tablet formulation evaluated in a 2012 observational breast-radiotherapy study contained resveratrol, lycopene, vitamin C, and anthocyanins. It was administered as two tablets daily from 10 days before radiotherapy through 10 days after treatment, alongside standard topical prophylaxis, to assess prevention of acute radiation-associated skin toxicity. The study reported lower rates of grade 2–3 skin toxicity in some prespecified subgroups, but it was observational and does not establish clinical efficacy. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3283474/))

Brand names

Ixor